Skip to main content
ALHC $6.72 -11.81%
ALHC logo
ALHC · Alignment Healthcare, Inc.
Track ALHC — free
Market Cap
$1.41B
Shares
209.27M
Volume · Nov 18 6.79M Avg daily vol (3M) 8.05M
All webcasts

Annual General Meeting · 2026-06-04

Alignment Healthcare, Inc. (ALHC) June 4, 2026 Annual General Meeting Transcript

Concluded Jun 4, 2026 Audio replay
Jun 4, 2026 13:25 12 turns
Period
2026-06-04
Runtime
13:25
Sources
2 artifacts

Transcript & audio

13:25 Audio

Good morning, and welcome to Alignment Healthcare's 2026 Annual Stockholders Meeting. I'm Harrison Jewell, Alignment's Senior Vice President, Finance. All attendees except for presenters are in a listen-only mode. Please note that the meeting is being recorded. A replay of the meeting will be available on our Investor Relations website for a limited time. We will conduct the business portion of this meeting first. Following the presentation of the proposals to be voted on at this meeting, we will respond to any questions related to the proposals. Stockholders can submit questions through the text box on your screen. After the closing of the polls on the proposal to be voted on, we will announce preliminary voting results. Following the conclusion of the formal business

John Kao Chairman

Thank you, Harrison.

John Kao Chairman

Good morning. I am John Kayo, Chairman of the Board of Directors, Founder and CEO of Alignment Healthcare, Inc., and I will be presiding at this meeting. On behalf of the Board and the Officers of the Company, I am pleased to welcome you to join us today. I'd like to welcome all of you to the 2026 Annual Meeting of Stockholders. I have been advised by Christopher Joyce, our Chief Legal and Administrative Officer and Corporate Secretary, that a quorum is present for the meeting virtually or by proxy. And so in accordance with the bylaws of the company, I can call to order the Annual Meeting of Stockholders. In addition to Mr. Zhao and Mr. Joyce, joining me today are Joseph Konobiecki, our Vice Chairman of the Board and Executive Vice President of Corporate Affairs, and Jim Head, our Chief Financial Officer. Also present are other members of the Board of Directors, including Margaret McCarthy, our Lead Independent Director. Additionally, present at the meeting are representatives of Deloitte & Touche LLP, our Independent Registered Public Accounting Firm. Thank you for attending our 2026 virtual annual meeting. All of our stockholders were mailed a notice of internet availability, directing stockholders to our proxy statement and annual report, containing information about the company and its business. Copies of those documents are available on the meeting website, as well as on our investor relations website and through the site maintained by the Securities and Exchange Commission at www.scc.gov. Links to access the agenda and rules of conduct for the meeting appear on your screen. It is our intention to conduct this meeting in accordance with this agenda and the rules. As noted, an opportunity is provided for questions following the presentation of the proposals to be voted on at this meeting. As stated in the Rules of Conduct, we ask that any questions or remarks be related to the proposals on the agenda and that you limit your questions or remarks to one for each stockholder. If we are unable to respond to any relevant questions during the allotted time, we will provide answers promptly after the meeting Thank you for your cooperation with these rules. Mr. Joyce will act as Secretary of this meeting and has been designated by the Board as Inspector of Elections for this meeting. Mr. Joyce will receive proxies, count the votes, and report the voting results. He has previously been dewey-sworn as Inspector of Elections and has completed the examination of proxies. Mr. Joyce will now report on the mailing of the notice of this meeting and the presence of a quorum.

Thank you, Mr. Chairman. The board fixed April 6, 2026 as the record date for stockholders entitled to vote at this meeting. The meeting is held pursuant to a notice mailed or made available via the Internet on or about April 24, 2026 to each stockholder of record on April 6, 2026, who is entitled to vote. Beta NXT has furnished an affidavit as to the mailing of the notice regarding the availability of proxy materials and annual reports. Aquinity, the transfer agent of our common stock, has furnished us with a certified list of common stockholders of the company as of the close of business on the record date of April 6, 2026. The list of stockholders entitled to vote at this meeting has been available at the company's Executive offices for the past 10 days. All documents concerning the call and notice of this meeting will be filed with the records of the company. There are approximately 206,730,723 shares of our common stock issued and outstanding and entitled to vote at this meeting. There are represented in person or by proxy 194,101,384 shares, which is 93.9% of all stock entitled to vote at this meeting. And I certify that, as required by the company's bylaws, the holders of a sufficient number of shares of stock entitled to vote are present in person or proxy, and that a quorum is therefore present.

John Kao Chairman

Next, we will review the items of business to be voted on at this meeting. The polls are now open for voting on all matters to be presented. If you would like to vote at this meeting, please do so via the online voting platform now or properly following the review of the proposals. If you already have voted online by phone or by returning a valid proxy, it will not be necessary to vote again at this meeting unless you wish to change your vote. After the proposals are reviewed, we will respond to any relevant questions. Stockholders who are properly registered to attend this meeting may submit questions or comments through the text box on your screen. Mr. Joyce will review the questions submitted and will read out loud any germane questions before Mr. Head, Mr. Joyce, or I respond. If you have a question, please submit it now to make sure it is received in a timely manner for a review and response. Following the Q&A session, we will close the polls. We will not accept ballots, proxies, or revocations or changes after the closing of the polls. Mr. Secretary, please proceed.

At this meeting, the stockholders are asked to vote on three matters. Proposal number one is the election of three Class II directors of the company. Each director elected today will hold office for a three-year term until the annual meeting held in the year 2029 and to serve until his or her successor is elected and qualified. The class two director nominees are Jody Bilney, former healthcare and marketing senior executive, David Hodgson, managing director, vice chairman, and partnership committee member at General Atlantic, a global growth equity firm, Jacqueline Kosikoff, former healthcare executive and managing partner at Moriah Partners, an investment firm. As disclosed in a proxy statement, our board recommends a vote for the election of each of Ms. Bilney, Mr. Hodgson, and Dr. Koskopf. Proposal 2 is the ratification of the board's selection of Deloitte & Touche LLP as the company's independent registered public accounting firm for the current fiscal year, which ends on December 31, 2026. As disclosed in a proxy statement, our board recommends a vote for the ratification of the board's selection of Deloitte & Touche LLP as the company's independent registered public accounting firm for the current fiscal year. Proposal 3 is the approval, on an advisory basis, of the compensation of our named executive officers as disclosed in the proxy statement in accordance with Section 14A of the Securities and Exchange Act of 1934. As disclosed in the proxy statement, the Board recommends that you vote for the approval on an advisory basis of the compensation of our named Executive Officers.

John Kao Chairman

That concludes the presentation of the proposals on which stockholders have been asked to vote at today's meeting. We will now address any questions related to these proposals. Mr. Secretary, are there any questions? Mr. Chairman, there are no questions. Thank you, Mr. Secretary. That concludes the presentation of the items of business on which stockholders have been asked to vote at today's meeting. If any stockholders are voting via the online meeting platform, I suggest they complete that process now. We will take a brief pause for anyone who still wishes to vote. The polls are now closed. I ask that Mr. Joyce, in his capacity as the inspector of election, tally the votes of stockholders present at the meeting together with the votes of stockholders by proxy and then provide preliminary results regarding the proposals presented at this meeting.

Results of voting are subject to a final count of all votes cast. Pursuant to the preliminary voting results that I have reviewed in my capacity as inspector of election, I can confirm that Ms. Bilney, Mr. Hodgson, and Dr. Kosakov have been elected as Class II directors to serve a three-year term until the 2029 annual stockholders meeting. The appointment of Deloitte and Touche LLP as our independent registered public accounting firm for the current fiscal year ending December 31, 2026 has been ratified, and stockholders have approved on an advisory basis the compensation of our named executive officers as disclosed in the proxy statement. The certified final voting tally will be included with the minutes of this meeting. Please note that we expect to report the final voting results on a current report on Form 8K with the SEC within four business days following this meeting.

John Kao Chairman

Thank you, Mr. Secretary. There being no other business, our meeting is now adjourned. On behalf of the Board of Directors of Alignment Healthcare, I would again like to express my My sincere appreciation to the stockholders who attended the meeting, as well as those who had submitted their proxies but were not able to be present virtually. At this time, I would like to make some brief remarks regarding the company. First, Mr. Joyce, will you provide an important disclaimer?

Please note that Mr. Kao's remarks may include forward-looking statements. Such statements are subject to risks and uncertainties and are based on assumptions that may prove to For a detailed discussion of the risk factors that could affect our actual results, please refer to the risk factors identified in our annual report for the year-ended December 31, 2025, and the other periodic reports we file with the SEC.

John Kao Chairman

Thank you, Chris. In 2025, we took important steps towards scaling our business and maturing our operating model. We improved adjusted MBR by 130 basis points and adjusted SG&A ratio by 140 basis points, all while delivering 46% year-over-year revenue growth and more than doubling membership outside of California. These financial outcomes reflect the visibility provided of our ABA technology platform, which leads to control over medical outcomes by our Care Anywhere clinical model. By caring for our seniors, just like we would our own mom or dad, we are enabling our members to live healthier lives and realizing the embedded earnings potential within our company. Put simply, we are doing well by doing good. As we look ahead, we remain focused on scaling responsibly, investing in our infrastructure and pursuing clinical innovation to deliver even better care to more seniors. We believe the investments we're making today will enable us to capitalize on a unique opportunity in the years ahead as the MA landscape increasingly rewards plans that deliver high-quality outcomes at a low In closing, we continue to deliver upon our promises to our shareholders each year by investing in the future from a position of strength. We are further widening our competitive mode and ensuring we can change healthcare at scale.

This concludes our meeting. On behalf of the board and management team, I would like to again express our thanks to all the stockholders who attended the annual meeting and who continued to support our mission of improving healthcare We're here one senior at a time. Thank you.

Full-screen source Call document